Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis

Authors

  • Carla Andrea Gobbi Universidad Nacional de Córdoba
  • Patricia Asbert Universidad Nacional de Córdoba
  • Paula Beatriz Alba Universidad Nacional de Córdoba
  • Jorge Resk Centro de Estudios Ecográficos Cuvertino
  • Gladys Dotto Hospital Córdoba
  • Marcela Demarchi Hospital Córdoba
  • Eduardo Cuvertino Centro de Estudios Ecográficos Cuvertino
  • Gustavo Alberto Pepe Universidad Nacional de Córdoba
  • Daniel Antonio Salica Universidad Nacional de Córdoba
  • Eduardo Horacio Albiero Universidad Nacional de Córdoba
  • Felipe Martínez Universidad Nacional de Córdoba

DOI:

https://doi.org/10.31053/1853.0605.v76.n3.21610

Keywords:

arthritis, atherosclerosis, ultrasound, rheumatoid arthritis

Abstract

Background: Mortality from cardiovascular disease (CVD) is increased in rheumatoid arthritis, not explained by traditional cardiovascular risk factors (CVRF), suggesting a role of inflammation. This process would occur early. The common sonographic markers of subclinical atherosclerosis (SA), are increased carotid intima-media thickness (cIMT) or the presence of carotid atherosclerotic plaque and they are closely related to CVD.

Aims: To evaluate sonographic markers and cardiovascular risk factors in early Arthritis (EA).

A case control study of patients with EA, defined by 3 joints swollen with <1 year of evolution, served consecutively from January 2011 to may 2013, matched with healthy controls, by sex, age and cardiovascular risk factors (hypertension, diabetes mellitus, cardiovascular disease -IAM and ACV, dyslipidemia, family history of CVD) was conducted. We studied demographics data, cardiovascular risk factors, carotid ultrasound measuring increased cIMT or the presence of carotid atherosclerotic plaque in Common Carotid Artery (CCA) and Carotid Bulb (BC), laboratory test that included cholesterol, LDL, HDL, triglycerides in mg%, C-reactive protein (CRP), erythrocyte sedimentation rate (ESR ), anti citrullinated peptide (ACCP), rheumatoid factor (RF), antinuclear antibodies (ANA). EA activity was measured by DAS 28, considering high disease activity (HDA) 5.1; moderate (MDA) from 5.1 to 3.2; and low (LDA) <3.2. Statistics: test Mann-Whitney and chi-square were used, p <0.05 was significant. Results: 25 women, 5 men, average age 43 years (DS 14.7) and 30 controls were included. The average DAS 28 was 4, 8 ± 1. 8; 47% had HDA, 33%MDA and 20%BDA. Both groups had similar values cIMT CCA (0, 57 ± 0.10 mm vs. 0.58 ± 0.15 mm, respectively, P = 0.82) and cIMT BC (0.18mm ± 0.67 vs 0.62 ± 0.15 mm respectively, P = 0.47). There were no carotid plaques. The median total cholesterol was 181,5 vs 183,5 (p = 0.35); triglycerides 99 vs 92,5 (p = 0.68); HDL 54,5 vs 52,5 (p = 0.921 and LDL 105 vs 110 (p = 0.27) in EA and controls respectively. The cIMT CCA and CB were not related to RF, ACCP, CRP, DAS 28 and smoking (NS). There was no difference in other cardiovascular risk factors

Conclusions: Ultrasound evidence of atherosclerosis subclinical markers was not found in this study, suggesting that this process may occur after a year of diagnosis.

Downloads

Author Biographies

  • Carla Andrea Gobbi, Universidad Nacional de Córdoba

    Professor in Medicine and Surgery. UNC

    Professor of the Chair of Medical Clinic I Hospital Córdoba. Faculty of Medical Sciences. UNC

    Rheumatologist of the Allende Sanatorium.

  • Patricia Asbert, Universidad Nacional de Córdoba


    Medical Specialist in Medical Clinic

    Specialist in Rheumatology

    Medical Doctor of the Hospital Córdoba

  • Paula Beatriz Alba, Universidad Nacional de Córdoba

    Professor of Medicine and Surgery

    Associate Professor of the Semiology Chair, UHMI N ° 3, Hospital Córdoba, FCM, UNC

    Head of the Rheumatology Unit of the Córdoba Hospita

  • Jorge Resk, Centro de Estudios Ecográficos Cuvertino

    Specialist in Cardiology

    Doctor of the Center for Ultrasound Studies Cuvertino

  • Gladys Dotto, Hospital Córdoba

    Head of the Córdoba Hospital Laboratory

    Clinical Biochemistry Specialist

  • Marcela Demarchi, Hospital Córdoba

    Head of the Immunology Section of the Laboratory Service of the Córdoba Hospital. 

    Biochemistry specialist in Immunology

  • Eduardo Cuvertino, Centro de Estudios Ecográficos Cuvertino

    Specialist in Diagnostic Imaging

    Medical Director of the Center for Ultrasound Studies Cuvertino

  • Gustavo Alberto Pepe, Universidad Nacional de Córdoba

    Profesor Adjunto de la Cátedra de Clínca Médica I de la Facultad de Ciencias Médicas de la Universidad Nacional de Córdoba. 

    Director del centro de Formación en Clínica Médica San Juan Bautista Catamarca. 

  • Daniel Antonio Salica, Universidad Nacional de Córdoba

    Professor of Medicine and Surgery

    Head of the Chair of Medical Clinic II, UHMI N ° 2, San Roque Hospital, FCM, UNC

  • Eduardo Horacio Albiero, Universidad Nacional de Córdoba

    Rheumatology Specialist

    Postgraduate Director of the Rheumatology Specialist Career, Secretary of Health Sciences Graduates, FCM, UNC

  • Felipe Martínez, Universidad Nacional de Córdoba


    Prof Dr. in Medicine and Surgery

    Former Head of the Chair of Medical Clinic I, UHMI N ° 3, Hospital Córdoba, FCM, UNC

References

Shoenfeld Y, Gerli R, Doria A, Matsuura E, Matucci Cerinic M, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation.2005; 112: pp. 3337-3347.

Van Doornum S, mccoll G, Wicks IP. Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum 2002; 46: pp. 862–873.

D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010.

A. Sandoo, J. J. C. S. Veldhuijzen van Zanten, G. S. Metsios, D. Carroll, and G. D. Kitas, “Vascular function and morphology in rheumatoid arthritis: a systematic review,” Rheumatology, vol. 50, pp. 2125–2139, 2011.

Meune C, Touz´e E, Trinquart L, Allanore Y. High risk of clinical cardiovascular events in rheumatoid arthritis: levels of associations of myocardial infarction and stroke through a systematic review and meta-analysis. Archives of Cardiovascular Diseases. 2010; 103(4): pp. 253–261.

Cavagna L, Boffini N, Cagnotto G, Inverardi F, Grosso V, Caporali R. Atherosclerosis and Rheumatoid Arthritis: More Than a Simple Association. Mediators of Inflammation. 2012; 2012: pp. 1-9.

Kitas J.,Toms T.,Goodson N.Cardiovascular co-morbidity in early rheumatoid arthritis Best Practice & Research Clinical Rheumatology 23 (2009) pp. 71–82.

Meune C, Touzé E, Trinquart L, Allanore Y. Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies. Rheumatology (Oxford) 2009;48: pp. 1309—13.

D. H. Solomon, E. W. Karlson, E. B. Rimm et al., “Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis,” Circulation, 2003; vol. 107, no. 9, pp. 1303– 1307.

Kaplan M., Cardiovascular complications of Rheumatoid Arthritis -Assessment, prevention and treatment. Rheum Dis Clin North Am. 2010 May ; 36(2): pp. 405–426.

Salmon J., Roman M. Subclinical Atherosclerosis in Rheumatoid Arthritis and Systemic Lupus Erythematosus Am J Med. 2008 October ; 121(10 Suppl 1): pp. S3–S8.

Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J. Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 2005;35: pp. 8–17.

Turesson C, Matteson EL. Cardiovascular risk factors, fitness and physical activity in rheumatic diseases. Curr Opin Rheumatol 2007;19: pp. 190–196.

Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52: pp. 722–732.

Hannawi S, Haluska B, Marwick TH, Thomas R. Atherosclerotic disease is increased in recent-onset rheumatoid arthritis: a critical role for inflammation. Arthritis Res Ther 2007;9(6): pp. R116.

Turesson C, mcclelland RL, Christianson TJ, et al. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 2007;66: pp. 70–75.

Del Rincon I, O’Leary DH, Freeman GL, Escalante A. Acceleration of atherosclerosis during the course of rheumatoid arthritis. Atherosclerosis Dec;2007 195(2): pp. 354–360.

Roman MJ, Naqvi TZ, Gardin JM, et al. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr 2006;19: pp. 943–954.

Kumeda Y, Inaba M, et al. Increased thickness of the arterial intima- media detected by ultrasonography in patients with rheumatoid arthritis. Arthritis Rheum 2002; 46: 1489-1497.

Baldassarre D, Amato M, Bondioli A, Sirtori C, Tremoli E. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stoke 2000; 31: 2426.

Wållberg Jonsson S, Backman C, et al. Increased prevalence of atherosclerosis inpatients with medium term rheumatoid arthritis. J Rheumatol 2001; 28: pp. 2597- 2602.

Veldhuijzen van Zanten J, Kitas GD. Inflammation, carotid intima-media thichkness and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther 2008; pp. 10:102.

Greenland P, Abrams J, Aurigemma G, Bond G, et al. Beyond secondary prevention: Identifying the high- risk patient for primary prevention: Noninvasive test of atherosclerosis burden: Writting group III. Circulation 2000; pp. 101: e16.

Van Doornum S, Mc Coll G, Wicks IP. Accelerated Atherosclerosis. An extraarticular feature of rheumatiod arthritis?. Arthritis Rheum 2002;46: 862-873.

Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-72.

American Diabetes Association. Standards of medical care in diabetes—2011: Position Statement Diabetes Care. 2011; 34(1):S11-61.

Ustrell-Roig X et al. Ictus. Diagnóstico y tratamiento de las enfermedades cerebrovasculares Rev Esp Cardiol. 2007;60(7):753-69.

Thygesen et al. JACC Universal Definition of Myocardial Infarction. ESC/ACCF/AHA/WHF Expert Consensus Document 2007;50 (22):2173–95.

Jimenez Ruiz CA, et al. Recomendaciones en el abordaje diagnóstico y terapéutico del tabaquismo. Documento de consenso Arch Bronconeumol 2003;39(1):35-41.

Grundy S, Cleeman J, Bairey Merz H, Bryan Brewer C, Clark L, Hunninghake D et al. Implications of recent clinical trials for the National Cholesterol Education Program ATP III guidelines. Circulation 2004; 110(2):227-239.

World Health Organization. Obesity. 2008 [Accessed October 22, 2009]. Available at: http://www.who.int/topics/obesity/en/

Aletaha D, Ward M M, Machold KP, nellvp. Remission and active disease in rheumatoid arthritis: defining criteria for disease activity states. Arthritis Rheum 2005; 52:2625-2636.

Anderson J, Zimmerman L, Caplan L, Michaud K. Measures of Rheumatoid Arthritis Disease Activity Arthritis Care & Research, 2011; 63(S11): S14–S36.

Wilson, PW, et. Al. Prediction of Coronary Heart Disease Using Risk Factor Categories. Circulation 1998 97 (18): 1837-1847.

Stein J., Korcarz C., Hurst T., Lonn E., Kendall C., Mohler E. Et al. ASE CONSENSUS STATEMENT Use of Carotid Ultrasound to Identify Subclinical Vascular Disease and Evaluate Cardiovascular Disease Risk: A Consensus Statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force Endorsed by the Society for Vascular Medicine. Journal of the American Society of Echocardiography February 2008 21(2): 93-111.

Bots M., Hoes A., Koudstaal P. et al. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation 1997; 96: 1432-1437.

O'Leary D., Polak J., Kronmal R. et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14–22.

Iglesias del Sol A, Bots M., Grobbee D. et al. Carotid intima-media thickness at different sites: relation to incident myocardial infarction. The Rotterdam Study. Eur Heart J 2002; 23: 934–40.

Park Y., Ahn C., Choi H. et al.: Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis Rheum 2002; 46: 1714-9.

Surdacki A, Martens-Lobenhoffer J, Wloch A, et al. Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2007; 56:809–819.

Alkaabi JK, Ho M, Levinson R, et al. Rheumatoid arthritis and macrovascular disease. Rheumatology. 2003;42:292-7.

Roman MJ, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006; 144:249–256.

Jonsson SW, Backman C, Johnson O, Karp K, Lundstrom E, Sundqvist KG, Dahlqvist SR: Increased prevalence of aterosclerosis in patients with medium term rheumatoid arthritis. Jrheumatol 2001, 28:2597-2602.12.

Cuomo G, Di Micco P, Niglio A, La Montagna G, Valentini G: Atherosclerosis and rheumatoid arthritis: relationships between intima-media thickness of the common carotid arteries and disease activity and disability. Reumatismo 2004, 56:242-246.

González-Juanatey C, Llorca J, Testa A, Revuelta J, et al. Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid artritis patients without clinically evident atherosclerotic disease. Medicine. 2003;82:407-13.

Alladi mohan, sujay sada, B. Siddhartha kumar, K.V.S. sarma, b. Vijayalakshmi devi P.V.L.N. srinivasa rao, d. Rajasekhar‡ & d.t. Katyarmal Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker. Indian J Med Res 140, September 2014, pp 379-386.

Schott L., Kao A., Cunningham A., Wildman R., Kuller L., Sutton-Tyrrell K., Et al. Do Carotid Artery Diameters Manifest Early Evidence of Atherosclerosis in Women with Rheumatoid Arthritis? JOURNAL OF WOMEN’S HEALTH 2009; 18(1): 21-29.

Carotti M, Salaffi F, Mangiacotti M, Cerioni A, Giuseppetti GM, Grassi W. Atherosclerosis in rheumatoid arthritis: the role of high-resolution B mode ultrasound in the measurement of the arterial intima-media thickness. Reumatismo. 2007 Jan-Mar; 59(1):38-49.

Giles J., Post W., Blumenthal R., Polak J., Petri M., Gelber A., et al. Longitudinal Predictors of Progression of Carotid Atherosclerosis in Rheumatoid Arthritis Arthritis Rheum. 2011 November ; 63(11): 3216–3225).

González-Gay M., González-Juanatey C. Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis. Arthritis Research & Therapy 2012, 14:105.

González-Juanatey C, Llorca J, González-Gay MA: Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease. Arthritis Res Ther 2011, 13:R101.

Ahmad S., Garg S., Dhar M., Srivastava S., Biswas D., Prasad S., Shirazi B., Srivastava R. Predictors of atherosclerosis in rheumatoid arthritis. Vasa 2012; 41: 353–359.

Ristic G., Lepic T., Glis B., Stanisavljevic D., Vojvodic D., Petronijevic M., Stefanovic D. Rheumatoid arthritis is an independent risk factor for increased carotid intima-media thickness: impact of anti-inflammatory treatment Rheumatology 2010;49:1076–1081.

Del Rincon I., Freeman G., Haas R., O’Leary D., Escalante A. Relative Contribution of Cardiovascular Risk Factors and Rheumatoid Arthritis Clinical Manifestations to Atherosclerosis. ARTHRITIS & RHEUMATISM Vol. 52, No. 11, November 2005, pp 3413–3423.

Elshereef R., Darwish A., Ali A., Abdel-kadar M., Hamdy L. Asymptomatic Atherosclerosis in Egyptian Rheumatoid Arthritis Patients and Its Relation to Disease Activity. International Journal of Rheumatology Volume 2015, Article ID 381931, 8 pages.

Del Rincon I., Polak J., O`Leary D., Battafarano D., Erikson J., Restrepo J., et al Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis Ann Rheum Dis. 2015 June; 74(6): 1118–1123.

Wu M, Zeng FF, Wang R, Seto WK, Pai P, et al. (2013) Atherosclerosis in Patients with Rheumatoid Arthritis. Rheumatol Curr Res S5: 002.

Zampeli E, Protogerou A, Stamatelopoulos K, Fragiadaki K, Katsiari CG, Kyrkou K, Papamichael CM, Mavrikakis M, Nightingale P, Kitas GD, Sfi kakis PP: Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study. Arthritis Res Ther 2012, 14:R44.

Ambrosino P.; Lupoli R.; Di Minno A.; Tasso M.; Peluso R.; Di Minno M. Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 2015; 113: 916–930.

Del Rincon I, Williams K, Stern MP, et al. Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects. Arthritis Rheum 2003;48:1833–1840.

Turesson C, Jacobson L, Rydén Å, et al. Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatol 2005;44:896–901.

Georgiadis AN, Voulgari PV, Argyropoulou MI, et al. Early treatment reduces the cardiovascular risk factors in newly diagnosed rheumatoid arthritis patients. Semin Arthritis Rheum 2008; 38:13–9.

Södergren A., Karp K., Boman K., Eriksson C., Lundström E., Smedby T. Et al. Atherosclerosis in early rheumatoid arthritis: very early endothelial activation and rapid progression of intima media thickness. Arthritis Research & Therapy 2010, 12:R158.

Gaetano Vaudo, Elena Bartoloni Bocci, Yehuda Shoenfeld, Giuseppe Schillaci, Ruihua Wu, Nicoletta Del Papa, Claudio Vitali, Francesco Delle Monache, Simona Marchesi, Elmo Mannarino, and Roberto Gerli. Precocious Intima-Media Thickening in Patients With Primary Sjögren’s síndrome. ARTHRITIS & RHEUMATISM Vol. 52, No. 12, December 2005, pp 3890–3897.

Mary J. Roman, M.D., Beth-Ann Shanker, A.B., Adrienne Davis, A.B., Michael D. Lockshin, M.D., Lisa Sammaritano, M.D., Ronit Simantov, M.D., Mary K. Crow, M.D., Joseph E. Schwartz, Ph.D., Stephen A. Paget, M.D., Richard B. Devereux, M.D., and Jane E. Salmon, M.D. Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus erythematosus N Engl J Med 2003;349:2399-406.

P. G. Vlachoyiannopoulos, P. G. Kanellopoulos, J. P. A. Ioannidis1, M. G. Tektonidou, I. Mastorakou2 and H. M. Moutsopoulos .Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 2003;42:645–651.

Sadhanah Aqashiah Mazlan1, Mohd Shahrir bin Mohamed Said2, Heselynn Hussein3, Khadijah binti Shamsuddin2, Shamsul Azhar Shah2, Hamidon basri. A study of intima media thickness and their cardiovascular risk factors in patients with psoriatic arthritis. Acta médica (hradec kralove) 2009;52(3):107–116.

Published

2019-08-29

Issue

Section

Original Papers

How to Cite

1.
Gobbi CA, Asbert P, Alba PB, Resk J, Dotto G, Demarchi M, et al. Subclinical markers of atherosclerosis and cardiovascular risk factors in early arthritis. Rev Fac Cien Med Univ Nac Cordoba [Internet]. 2019 Aug. 29 [cited 2025 Apr. 21];76(3):174-9. Available from: https://revistas.unc.edu.ar/index.php/med/article/view/21610

Similar Articles

1-10 of 148

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)